<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Appl Microbiol Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Appl Microbiol Biotechnol</journal-id><journal-title-group><journal-title>Applied Microbiology and Biotechnology</journal-title></journal-title-group><issn pub-type="ppub">0175-7598</issn><issn pub-type="epub">1432-0614</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2981745</article-id><article-id pub-id-type="pmid">20853106</article-id><article-id pub-id-type="publisher-id">2860</article-id><article-id pub-id-type="doi">10.1007/s00253-010-2860-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mini-Review</subject></subj-group></article-categories><title-group><article-title>Engineered polyketide biosynthesis and biocatalysis in <italic>Escherichia coli</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tang</surname><given-names>Yi</given-names></name><address><email>yitang@ucla.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095 USA </aff><aff id="Aff2"><label>2</label>Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095 USA </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>9</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>9</month><year>2010</year></pub-date><pub-date pub-type="ppub"><year>2010</year></pub-date><volume>88</volume><issue>6</issue><fpage>1233</fpage><lpage>1242</lpage><history><date date-type="received"><day>30</day><month>7</month><year>2010</year></date><date date-type="rev-recd"><day>18</day><month>8</month><year>2010</year></date><date date-type="accepted"><day>18</day><month>8</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2010</copyright-statement><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</license-p></license></permissions><abstract id="Abs1"><p>Polyketides are important bioactive natural products biosynthesized by bacteria, fungi, and plants. The enzymes that synthesize polyketides are collectively referred to as polyketide synthases (PKSs). Because many of the natural hosts that produce polyketides are difficult to culture or manipulate, establishing a universal heterologous host that is genetically tractable has become an important goal toward the engineered biosynthesis of polyketides and analogues. Here, we summarize the recent progresses in engineering <italic>Escherichia coli</italic> as a heterologous host for reconstituting PKSs of different types. Our increased understanding of PKS enzymology and structural biology, combined with new tools in protein engineering, metabolic engineering, and synthetic biology, has firmly established <italic>E. coli</italic> as a powerful host for producing polyketides.</p></abstract><kwd-group xml:lang="en"><title>Keyword</title><kwd>Biosynthesis</kwd><kwd>Megasynthase</kwd><kwd>Heterologous host</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2010</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Polyketides constitute an important family of structurally diverse natural products, which include many clinically useful drugs such as the antibiotics erythromycin and tetracycline, anticancer epothilone, and the anti-hypercholesterolemia lovastatin. The pharmaceutical values of many polyketides have led to intense efforts in recent decades toward understanding and engineering the corresponding biosynthetic pathways. These concerted efforts from several disciplines, such as biochemistry, structural biology, genetics, and metabolic engineering, have enabled many examples of rational and combinatorial biosynthesis of &#x0201c;unnatural&#x0201d; natural products, as well as enzymatic tools that can be used in the semisynthesis of natural product-derived targets (Baltz <xref ref-type="bibr" rid="CR5">2006</xref>; Weissman and Leadlay <xref ref-type="bibr" rid="CR63">2005</xref>; Olano et al. <xref ref-type="bibr" rid="CR46">2009</xref>).</p><p>Polyketides are synthesized by a family of multifunctional enzymes known as polyketide synthases (PKSs). PKSs assemble the core structures (or aglycons) of polyketides via the sequential Claisen-like condensations of extender units derived from caboxylated acyl-CoA precursors, in a head-to-tail fashion (Staunton and Weissman <xref ref-type="bibr" rid="CR55">2001</xref>). Based on the structures of the polyketide products, as well as biochemical features of the PKSs, PKSs are currently classified into types I, II, and III subgroups. Type I PKSs are megasynthases in which catalytic domains are typically found in a single polypeptide. A modular type I PKS, such as the 6-deoxyerythronolide B synthase (DEBS) (Donadio and Katz <xref ref-type="bibr" rid="CR12">1992</xref>), consists of multiple modules and each module catalyzes one round of chain elongation and modification. Linear juxtaposition of modules facilitates unidirectional transfer of the growing polyketide from the upstream to the downstream modules in assembly line-like fashion (Cane et al. <xref ref-type="bibr" rid="CR9">1998</xref>). An iterative type I PKS, such as the lovastatin nonaketide synthase (LovB) (Kennedy et al. <xref ref-type="bibr" rid="CR26">1999</xref>), is a monomodule megasynthase in which a single set of catalytic domains are used repeatedly in a highly programmed fashion. Type II PKSs (also known as bacterial aromatic PKSs) are composed of mostly dissociated, monofunctional enzymes that function repeatedly in the synthesis of a poly-&#x003b2;-ketone backbone (Hertweck et al. <xref ref-type="bibr" rid="CR17">2007</xref>). Type II PKSs are involved in the synthesis of aromatic polyketides, such as the aglycons of actinorhodin (McDaniel et al. <xref ref-type="bibr" rid="CR39">1993</xref>) and daunorubicin (Hutchinson <xref ref-type="bibr" rid="CR18">1997</xref>). In both type I and II PKSs, the minimal PKS components that are required to perform one round of decarboxylative condensation consist of a &#x003b2;-ketoacylsynthase (KS), an acyltransferase (AT), and a phosphopantethienylated acyl carrier protein (ACP) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The elongated polyketide product synthesized by the minimal PKS can be tailored by enzymes such as ketoreductase (KR), dehydratase (DH), enoylreductase (ER) or methyltransferase (MT), etc. Type III PKSs, such as chalcone synthase (Austin and Noel <xref ref-type="bibr" rid="CR3">2003</xref>), are homodimeric KSs that synthesize smaller aromatic compounds in bacteria, fungi, and plants. Products synthesized by the various types of PKSs can undergo different sets of post-PKS modifications by decorative enzymes encoded in the biosynthetic pathways, such as cyclases, oxygenases, glycosyltransferases, etc., to afford the structurally diverse natural products (Olano et al. <xref ref-type="bibr" rid="CR47">2010</xref>).
<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>General mechanisms involved in polyketide biosynthesis. <italic>KS</italic> ketosynthase, <italic>AT</italic> acyl transferase, <italic>ACP</italic> acyl carrier protein, <italic>KR</italic> ketoreductase, <italic>ER</italic> enoylreductase, <italic>DH</italic> dehydratase</p></caption><graphic xlink:href="253_2010_2860_Fig1_HTML" id="MO1"/></fig>
</p><p>Polyketides are synthesized mostly by soil-borne or marine actinomycetes bacteria and filamentous fungi. Type III polyketides can also be synthesized by plants. While these organisms can be prolific and impressive natural product chemists, many of them are unfortunately difficult to work with in both laboratory and industrial settings. The difficulties can be attributed to one of more of the following reasons: (1) the strain is difficult to culture (long doubling times) or domesticate; (2) the strain is genetically intractable and refractory toward common molecular biology tools; and (3) the polyketide biosynthetic pathways are weakly expressed or silent under laboratory culturing conditions, resulting in low polyketide titers. To overcome these limitations, one important goal toward engineered biosynthesis of polyketides is the establishment of robust heterologous hosts (Pfeifer and Khosla <xref ref-type="bibr" rid="CR49">2001</xref>).</p><p>The workhorse organism <italic>Escherichia coli</italic> has emerged to be a useful heterologous host for the reconstitution, manipulation, and optimization of polyketide biosynthesis in recent years. The choice of <italic>E. coli</italic> is an obvious one from the start due to the (1) ease of culturing and fast growth characteristics; (2) availability of superior genetic tools; (3) well-understood primary metabolism; and (4) the lack of endogenous polyketide pathways that may crosstalk or interfere with transplanted pathways. However, <italic>E. coli</italic> also has significant drawbacks as a heterologous host, including lack of compatible post-translational enzymes, such as the phosphopantetheinyl transferase that can modify foreign ACPs (Quadri et al. <xref ref-type="bibr" rid="CR52">1998</xref>); unavailability of polyketide building blocks; and difficulties in efficient translation and functional folding of key biosynthetic components, such as megasynthases and the P450 family of enzymes. Fortunately, many of these limitations have been addressed in recent years via metabolic engineering, protein engineering, and synthetic biology efforts. As a result, polyketides synthesized by all three types of PKSs have been produced in <italic>E. coli.</italic> While some compounds are only synthesized at milligram per liter scales, a few complex polyketides have been produced at nearly gram per liter titers after optimization (Murli et al. <xref ref-type="bibr" rid="CR43">2003</xref>; Leonard et al. <xref ref-type="bibr" rid="CR34">2008</xref>). In addition, using enzymes mined from the biosynthetic pathways, <italic>E. coli</italic> has also been engineered to be a platform for biocatalytic synthesis of polyketide-based, clinically relevant drugs (Xie et al. <xref ref-type="bibr" rid="CR66">2007</xref>). These successes represent important milestones in outfitting <italic>E. coli</italic> as a powerful host for polyketide biosynthesis, and a few of these examples will be highlighted in this minireview.</p></sec><sec id="Sec2"><title>Biosynthesis of type I PKS in <italic>E. coli&#x02014;</italic>the 6-deoxyerythronolide B synthase success story</title><p>The most successful example of using <italic>E. coli</italic> as a heterologous host for polyketide biosynthesis is that of the total biosynthesis of 6-deoxyerythronolide B (6-dEB) and erythromycin (Pfeifer et al. <xref ref-type="bibr" rid="CR50">2001</xref>). 6-dEB is the 14-membered macrocyclic core of the antibiotic erythromycin synthesized by <italic>Saccharopolyspora erythraea</italic>. The PKS that synthesizes 6-dEB is DEBS, which consists of three large polypeptides, each exceeding 300&#x000a0;kDa in molecular weight. Together, DEBS contains one loading module and six extension modules, utilizes propionyl-CoA as a starter unit and six (<italic>2S</italic>)-methylmalonyl-CoA as extender units (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Each module (DEBS module 1, module 2, etc.) is responsible for one chain extension cycle, as well as the reductive tailoring of resulting &#x003b2;-keto product. At the end of the biosynthetic assembly, a thioesterase (TE) domain fused to the C-terminus of module 6 catalyzes the macrocyclization of the linear polyketide to yield 6-dEB (Khosla et al. <xref ref-type="bibr" rid="CR28">2007</xref>). The cyclized 6-dEB is then modified by a series of post-PKS enzymes, including hydroxylation and glycosylation, to yield the bioactive natural products erythromycin A&#x02013;D.
<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Biosynthesis of 6-dEB and erythromycin</p></caption><graphic xlink:href="253_2010_2860_Fig2_HTML" id="MO2"/></fig>
</p><p>Since the initial discovery of the <italic>ery</italic> genes that encode DEBSs (Cortes et al. <xref ref-type="bibr" rid="CR10">1990</xref>; Donadio et al. <xref ref-type="bibr" rid="CR13">1991</xref>), DEBS has served as the model system to study and engineer modular type I PKSs. The linear arrangement of domains and modules inspired the colinearity rule, which allows precise prediction and manipulation of the product structure from PKS protein sequence for most of the modular PKSs. Numerous 6-dEB, erythromycin, and other analogues were synthesized through domain/module deletions, insertions, and replacements (Cane <xref ref-type="bibr" rid="CR8">2010</xref>). These efforts were first performed in the natural producer <italic>S. erythraea</italic> (Marsden et al. <xref ref-type="bibr" rid="CR38">1998</xref>) and model <italic>Streptomyces</italic> hosts (Kao et al. <xref ref-type="bibr" rid="CR21">1994</xref>; Xue et al. <xref ref-type="bibr" rid="CR68">1999</xref>) with great success. However, despite these efforts, an <italic>E. coli</italic> platform for producing 6-dEB and manipulation of DEBS was still being sought after. Pfeifer et al. reported the first total biosynthesis of 6-dEB in a highly engineered <italic>E. coli</italic> strain in 2001 (Pfeifer et al. <xref ref-type="bibr" rid="CR50">2001</xref>). Much of the strain engineering was focused on correctly functionalize the DEBS proteins and transplanting pathways for accumulation of the methylmalonyl-CoA building blocks. First, the <italic>sfp</italic> gene from <italic>Bacillus subtilis</italic> (Lambalot et al. <xref ref-type="bibr" rid="CR30">1996</xref>) was integrated into the chromosome of <italic>E. coli</italic> under a T7 promoter to assure the complete phosphopantetheinylation of the seven ACP domains in recombinant DEBS. To increase the concentrations of propionyl-CoA and methylmalonyl-CoA, the propionate catabolism genes in the <italic>prpRBCD</italic> operon were deleted, while a T7 promoter was inserted before the <italic>prpE</italic> gene, of which the encoded PrpE can convert propionate to propionyl-CoA. The resulting strain was named BAP1 and will also be mentioned later in this review. In addition, the propionyl-CoA carboxylase (<italic>pcc</italic>) gene from <italic>Streptomyces coelicolor</italic> was coexpressed to produce (<italic>2S</italic>)-methylmalonyl-CoA from propionyl-CoA. Therefore, both (<italic>2S</italic>)-methylmalonyl-CoA and propionyl-CoA can be synthesized and accumulated inside BAP1 when exogenous propionate was supplied.</p><p>Upon transformation of the plasmids that encode all three of the DEBS megasynthases, 6-dEB was successfully produced in <italic>E. coli</italic> for the first time at a titer of 20&#x000a0;mg/L. 6-dEB was produced ~100&#x000a0;mg/L by high cell density fed-batch fermentation upon the coexpression of an accessory thioesterase TEII from <italic>S. erythraea</italic> (Pfeifer et al. <xref ref-type="bibr" rid="CR51">2002</xref>). Lau et al. found that excess ammonia concentration dramatically decreased the <italic>E. coli</italic> cell productivity; hence, ammonia was maintained below 40&#x000a0;mM throughout the fermentation process, while high phosphate concentration was maintained to support cell growth (Lau et al. <xref ref-type="bibr" rid="CR31">2004</xref>). When DEBS proteins were expressed in BAP1 from two plasmids (Murli et al. <xref ref-type="bibr" rid="CR43">2003</xref>) of different origins of replications, the titer was further improved to 1.1&#x000a0;g/L, which was comparable to that by the best <italic>S. coelicolor</italic> host.</p><p>Many metabolic engineering efforts that aim at improving the yield of 6-dEB soon followed the initial success by Pfeifer and Khosla. For example, the B12-dependent methylmalonyl-CoA mutase-epimerase pathway from <italic>Propionibacterium shermanii</italic> was introduced into BAP1 (Dayem et al. <xref ref-type="bibr" rid="CR11">2002</xref>) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This pathway can first convert succinyl-CoA to (<italic>2R</italic>)-methylmalonyl-CoA, which can then be epimerized to (<italic>2S</italic>)-methylmalonyl-CoA. The advantage of this pathway is that the extender unit (<italic>2S</italic>)-methylmalonyl-CoA can be provided independently of the starter unit propionyl-CoA. Wang et al. overexpressed the <italic>S</italic>-adenosylmethionine synthetase MetK from <italic>Streptomyces spectabilis</italic>, and the specific production of 6-dEB was improved from 10.86 to 20.08&#x000a0;mg/L/OD<sub>600</sub> (Wang et al. <xref ref-type="bibr" rid="CR60">2007</xref>). The authors attributed the improvement in 6-dEB titers to the increased synthesis of signaling molecules such as AI-2. Recently, Zhang et al. deleted <italic>E. coli ygfH</italic> gene, which encodes the propionyl-CoA:succinate CoA transferase and increased 6-dEB titer in the parent strain from 65 to 129&#x000a0;mg/L under shake flask conditions (Zhang et al. <xref ref-type="bibr" rid="CR71">2010</xref>). Wang and Pfeifer (<xref ref-type="bibr" rid="CR59">2008</xref>) also integrated the <italic>pcc</italic> genes (<italic>pccB</italic> and <italic>accA1</italic>) and the entire genes encoding DEBS (~30&#x000a0;kb) into the <italic>E. coli</italic> chromosome to create a plasmid-free strain YW9. This strain produced 6-dEB at a titer of 0.52&#x000a0;mg/L at 30&#x000b0;C and remarkably can produce 0.11&#x000a0;mg/L 6-dEB in <italic>E. coli</italic> even at 37&#x000b0;C. Some other metabolic engineering attempts, including overexpressing the <italic>E. coli</italic> methylmalonyl-CoA mutase, <italic>sbm</italic>, or deleting the methylmalonyl-CoA decarboxylase <italic>ygfG</italic>, did not have an positive impact on the production of 6-dEB. Similarly, overexpressing the malonyl/methylmalonyl-CoA ligase (MatB) pathway also did not lead to any improvement, although methylmalonyl-CoA was accumulated to 90% of the intracellular acyl-CoA pool (Murli et al. <xref ref-type="bibr" rid="CR43">2003</xref>).</p><p>Utilizing the <italic>E. coli</italic> platform, Pfeifer et al. (<xref ref-type="bibr" rid="CR50">2001</xref>) were able to generate an analogue of 6-dEB by replacing the loading module with that from <italic>rif</italic> PKS. Taking advantage of the broad substrate specificity of the DEBS loading didomain, Kennedy et al. (<xref ref-type="bibr" rid="CR27">2003</xref>) overexpressed the acetoacetyl-CoA:acetyl-CoA transferase AtoD in <italic>E. coli</italic>. When butyrate was supplied, butyryl-CoA was synthesized as the starter unit and the corresponding 6-dEB analogue (15-methyl-6-dEB) was generated by <italic>E. coli.</italic> Furthermore, by inactivating the loading didomain of DEBS followed by supplementation of various acyl-thioesters starter units, additional 6-dEB analogues were produced (Murli et al. <xref ref-type="bibr" rid="CR44">2005</xref>).</p><p>To complete erythromycin biosynthesis in <italic>E. coli</italic>, Peiru et al. identified 16 genes from the megalomicin (<italic>meg</italic>) biosynthetic pathway that encoded the tailoring enzymes that can convert 6-dEB to erythromycin C, as well as a rRNA methyltransferase (ErmE) that was necessary to confer host self-resistance (Peiru et al. <xref ref-type="bibr" rid="CR48">2005</xref>). Two additional plasmids encoding the <sc>l</sc>-mycarose and <sc>d</sc>-desosamine operons were constructed. The <sc>l</sc>-mycarose operon contains genes necessary for synthesis of TDP-<sc>l</sc>-mycarose, a erythronolide B TDP-mycarose glycosyltransferase, and 6dEB 6-hydroxylase; whereas the <sc>d</sc>-desosamine operon contains genes required for the synthesis of TDP-<sc>d</sc>-desosamine, a TDP-<sc>d</sc>-desosamine glycosyltransferase, and 6dEB 12-hydroxylase. Then, an engineered <italic>E. coli</italic> strain expressing DEBS and all the necessary tailoring enzymes (23 genes in total) was constructed, which produced the antibacterial erythromycin C at a titer of 0.4&#x000a0;mg/L and erythromycin D at that of 0.5&#x000a0;mg/L. The final conversion to the most desired erythromycin A, which requires the action of an <italic>O</italic>-methyltransferase, has not been achieved to date.</p></sec><sec id="Sec3"><title>Biosynthesis of other complete and partial type I polyketides in <italic>E. coli</italic></title><p>Epothilones are potent anticancer agents (tubulin inhibitors) that were originally isolated from <italic>Sorangium cellulosum</italic> (Bollag et al. <xref ref-type="bibr" rid="CR7">1995</xref>). Epothilones are synthesized by a hybrid PKS-nonribosomal peptide synthetases (NRPS) pathway. The NRPS module synthesizes the thiazole portion of the molecule, while the PKS portion assembles the macrolide core. The 56-kb <italic>epo</italic> gene cluster consists of one loading module (EpoA), one NRPS module (EpoB), eight PKS modules in three polypeptides (EpoD, EpoE, and EpoF) and a P450 epoxidase (EpoK) (Julien et al. <xref ref-type="bibr" rid="CR20">2000</xref>; Tang et al. <xref ref-type="bibr" rid="CR56">2000</xref>). The size of the entire cluster therefore presents a challenge to reconstitute in <italic>E. coli</italic>. Boddy et al. (<xref ref-type="bibr" rid="CR6">2004</xref>) used a precursor directed method to first demonstrate epothilone production from the BAP1 strain. This was accomplished using a three-plasmid system to express EpoD module 6, EpoE, and EpoF in soluble forms. To mimic the upstream substrate of EpoD module 6, an advanced <italic>N</italic>-acetyl cysteamine (SNAC) thioester precursor was synthesized to be recognized by the KS domain of module 6. When the precursor was supplemented to the BAP1 strain, epothilone C was produced at a titer of 0.7&#x000a0;mg/L, which is comparable to that of the wild-type native host.</p><p>Subsequently, Mutka et al. (<xref ref-type="bibr" rid="CR45">2006</xref>) expressed the full-length <italic>epo</italic> PKS-NRPS in <italic>E. coli</italic> and observed production of epothilone C and D. To accomplish this milestone, difficulties in molecular biology were first overcome through custom gene synthesis and strategic restriction site placement. At the same time, the GC-rich <italic>epo</italic> genes were codon optimized to ensure efficient translation. To further improve the protein expression and folding, the T7 promoter was changed to the arabinose-inducible P<sub>BAD</sub> promoter, and chaperone proteins were coexpressed. Soluble expression of larger portions of the <italic>epo</italic> PKS modules allowed them to perform the precursor-directed biosynthesis using much simpler SNAC-based substrates. Feeding of (<italic>E</italic>)-2-methyl-3-(2-methylthiazol-4-yl) acrylic acid to BAP1 encoding the last seven modules (EpoD, EpoE, and EpoF) of the <italic>epo</italic> biosynthetic pathway resulted in the expected synthesis of epothilone C. With this platform, novel epothilone analogues can be generated in a more straightforward fashion through the feeding of custom-synthesized precursors. The epothilone example therefore shows that synthetic biology approaches can play key roles in overcoming difficulties associated with reconstitution of large pathway into <italic>E. coli</italic>.</p><p>The epothilone PKS currently represents the largest modular type I PKS reconstituted in <italic>E. coli.</italic> Other large macrolides require more PKS modules and therefore are even more daunting obstacles. One such example is the important antibacterial agent rifamycin, of which the biosynthetic gene cluster is ~90&#x000a0;kb (Schupp et al. <xref ref-type="bibr" rid="CR54">1998</xref>; August et al. <xref ref-type="bibr" rid="CR2">1998</xref>). The biosynthesis pathways of rifamycin and other ansamycins are primed by 3-amino-5-hydroxybenzoic acid (AHBA), which is synthesized by a dedicated metabolic pathway consists of seven enzymes. AHBA then serves as the starter unit for the first megasynthases in the <italic>rif</italic> pathway, RifA, which is a ~530&#x000a0;kDa NRPS/PKS megasynthases and cannot be solubly expressed in <italic>E. coli</italic>. Toward heterologously reconstituting the <italic>rif</italic> pathway in BAP1, Khosla and coworkers first successfully expressed a cassette of seven genes to produce AHBA. Among them, two of the genes were cloned from the ansamycin pathway because the corresponding RifG and RifJ cannot be expressed solubly (Watanabe et al. <xref ref-type="bibr" rid="CR61">2003</xref>). To overcome the enormous size of RifA, the same research group first dissected RifA into two smaller, bimodular enzymes (~240 and ~290&#x000a0;kDa). To subsequently reestablish communication and substrate transfer between the separated proteins, intermodular peptide linkers from the DEBS pathway (those between DEBS modules 2 and 3) were appended to the C- and N-termini of the upstream and downstream RifA modules, respectively (Watanabe et al. <xref ref-type="bibr" rid="CR61">2003</xref>). This linker approach is an important strategy that can be used to split otherwise unmanageable megasynthases into considerably smaller pieces while maintaining the crucial crosstalk and specificity. Finally, by combining the AHBA pathway and the reengineered RifA parts, the key intermediate P8_1-OG was produced in BAP1 at a titer of 2.5&#x000a0;mg/L.</p></sec><sec id="Sec4"><title>Biosynthesis of type II polyketides in <italic>E. coli</italic></title><p>In contrast to the success of reconstituting type I PKSs, <italic>E. coli</italic> has been a complete disappointment as a host for type II PKSs from actinomycete despite intense efforts by many groups. The main obstacle is the insoluble expression of the <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\hbox{K}}{{\hbox{S}}_\alpha } - {\hbox{K}}{{\hbox{S}}_\beta } $$\end{document}</tex-math><inline-graphic xlink:href="253_2010_2860_Article_IEq1.gif"/></alternatives></inline-formula> heterodimer (combined size of ~90&#x000a0;kDa), which is part of the minimal PKS and synthesizes the full poly-&#x003b2;-ketone backbone (Hertweck et al. <xref ref-type="bibr" rid="CR17">2007</xref>). <inline-formula id="IEq2"><alternatives><tex-math id="M2">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\hbox{K}}{{\hbox{S}}_\alpha } $$\end{document}</tex-math><inline-graphic xlink:href="253_2010_2860_Article_IEq2.gif"/></alternatives></inline-formula> is the active subunit and catalyzes the repeated Claisen-like condensations, while <inline-formula id="IEq3"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\hbox{K}}{{\hbox{S}}_\beta } $$\end{document}</tex-math><inline-graphic xlink:href="253_2010_2860_Article_IEq3.gif"/></alternatives></inline-formula> has been associated with chain length determination (Tang et al. <xref ref-type="bibr" rid="CR57">2003</xref>). Different attempts to express <inline-formula id="IEq4"><alternatives><tex-math id="M4">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\hbox{K}}{{\hbox{S}}_\alpha } - {\hbox{K}}{{\hbox{S}}_\beta } $$\end{document}</tex-math><inline-graphic xlink:href="253_2010_2860_Article_IEq4.gif"/></alternatives></inline-formula> solubly in <italic>E. coli</italic>, including translational fusion to other proteins, to each other, or to dimerizing peptides, have all resulted in 100% of the highly expressed complex residing in the insoluble fraction of <italic>E. coli</italic> total protein. The exact reason for the insoluble expression is not known, but we hypothesize that it could be due to incompatibilities between the rates of protein synthesis, subunit folding, and heterodimerization, the latter of which is likely the most important factor.</p><p>Recently, our group engineered a fungal nonreducing PKS capable of synthesizing the poly-&#x003b2;-ketone backbone in <italic>E. coli</italic>, thereby indirectly bypassed the need for soluble <inline-formula id="IEq5"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\hbox{K}}{{\hbox{S}}_\alpha } - {\hbox{K}}{{\hbox{S}}_\beta } $$\end{document}</tex-math><inline-graphic xlink:href="253_2010_2860_Article_IEq5.gif"/></alternatives></inline-formula> expression (Zhang et al. <xref ref-type="bibr" rid="CR70">2008</xref>). Using the bikaverin synthase PKS4 from <italic>Gibberella fujikuroi</italic> (Linnemannstons et al. <xref ref-type="bibr" rid="CR35">2002</xref>), which is a megasynthase that can be expressed solubly in <italic>E. coli</italic> (Ma et al. <xref ref-type="bibr" rid="CR36">2007</xref>), Ma and coworkers first showed that ketoreductase (<italic>act</italic> KR) and cyclases associated with bacterial type II PKS can modify the polyketide backbone synthesized by PKS4. However, the built-in product template (PT) domains of PKS4 cyclized most of the products in a fungal-specific regioselectivity, which is considerably different than those of type II PKS products (Thomas <xref ref-type="bibr" rid="CR58">2001</xref>). To inactivate the built-in, fungal-specific cyclization activities of PKS4, Zhang et al. extracted the minimal PKS components (including the KS-AT didomain and ACP) from PKS4 (Zhang et al. <xref ref-type="bibr" rid="CR70">2008</xref>). These components were efficient in synthesizing a complete nonaketide backbone in <italic>E. coli</italic>. Combining the PKS4 minimal PKS with an assortment of type II PKS tailoring enzymes led to the synthesis of compounds in BAP1 that were previously only observed from <italic>Streptomyces</italic>, including PK8 (Kramer et al. <xref ref-type="bibr" rid="CR29">1997</xref>) and SEK26 (McDaniel et al. <xref ref-type="bibr" rid="CR40">1995</xref>). The <italic>E. coli</italic> platform can be easily scaled up under fermentation conditions and afforded milligram quantities of aromatic polyketides. Other fungal nonreducing PKSs of different chain-length specificities may be similarly engineered toward the synthesis of aromatic polyketides of different sizes in <italic>E. coli.</italic>
</p></sec><sec id="Sec5"><title>Biosynthesis of plant type III polyketides in <italic>E. coli</italic></title><p>The type III PKSs provide the key structural scaffolds of a variety of plant secondary metabolites by catalyzing decarboxylative condensation between the starter unit, such as <italic>p</italic>-coumaroyl-CoA or cinnamoyl-CoA, and the extended unit malonyl-CoA. Depending on the specific activities of the type III PKSs, the product can be cyclized into different structures. The chalcone synthases (CHS) cyclize the products into flavanones, which can be further modified into to a variety of flavonoids (Weisshaar and Jenkins <xref ref-type="bibr" rid="CR62">1998</xref>). Stilbene synthase (STS) can cyclize the polyketide via a different regioselectivity to produce the stilbene backbone, which is the key intermediate in the biosynthesis of stilbenoids (Austin et al. <xref ref-type="bibr" rid="CR4">2004</xref>). Curcuminoid synthase (CUS) represents the non-cyclization type of type III PKSs that only catalyzes condensation reactions to generate curcuminoids (Abe and Morita <xref ref-type="bibr" rid="CR1">2010</xref>).</p><p>Horinouchi and coworkers used <italic>E. coli</italic> as a heterologous host for different plant type III PKSs and generated libraries of plant-specific polyketides from both simple amino acid and carboxylic acid precursors using different type III PKSs. First, an <italic>E. coli</italic> strain was engineered to overexpress phenylalanine ammonia lyase (PAL) from <italic>Rhodotorula rubra</italic> and 4-coumarate:coenzyme A ligase (4CL) from <italic>S. coelicolor</italic> A3(2). When supplemented with phenylalanine or tyrosine, the required starter units cinnamoyl-CoA or <italic>p</italic>-coumaroyl-CoA can be produced, respectively. Using this host, coexpression of CHS from the licorice plant <italic>Glycyrrhiza echinata</italic> resulted in the productions of pinocembrin chalcone and naringenin chalcone (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>; Hwang et al. <xref ref-type="bibr" rid="CR19">2003</xref>; Miyahisa et al. <xref ref-type="bibr" rid="CR41">2005</xref>). Similarly, resveratrol and pinosylvin were synthesized by replacing CHS with <italic>Arachis hypogaea</italic> STS and overexpressing <italic>Corynebacterium glutamicum</italic> acetyl-CoA carboxylase (ACC) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>; Katsuyama et al. <xref ref-type="bibr" rid="CR23">2007b</xref>). Finally, the coexpression of PAL, 4CL, CUS, and ACC in <italic>E. coli</italic> produced bisdemethoxycurcumin and dicinnamoylmethane (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>; Katsuyama et al. <xref ref-type="bibr" rid="CR24">2008</xref>). Hence, once a pathway for the biosynthesis of precursors is established, the <italic>E. coli</italic> host can be directed toward the synthesis of different type III polyketides by varying the choice of the key PKS.
<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Biosynthesis of flavonoids, stilbenoids, and curcuminoids</p></caption><graphic xlink:href="253_2010_2860_Fig3_HTML" id="MO3"/></fig>
</p><p>To produce structurally more diverse compounds, precursor-directed biosynthesis strategy was performed based on the above system. Various aromatic carboxylic acids were supplied and led to the synthesis of corresponding unnatural compounds (Katsuyama et al. <xref ref-type="bibr" rid="CR22">2007a</xref>, <xref ref-type="bibr" rid="CR25">2010</xref>). Additional coexpression of post-PKS modification enzymes introduced by a multi-plasmid approach can further tailor the natural or unnatural flavonols, flavones, methylated resveratrols, etc. (Miyahisa et al. <xref ref-type="bibr" rid="CR42">2006</xref>; Leonard et al. <xref ref-type="bibr" rid="CR32">2006</xref>; Yan et al. <xref ref-type="bibr" rid="CR69">2007</xref>).</p><p>To improve titer of flavanone biosynthesis in <italic>E. coli</italic>, Koffas and coworkers designed a series of experiments to optimize the availability of the key building block malonyl-CoA. Malonyl-CoA can be synthesized from acetyl-CoA by the enzyme ACC using biotin as a cofactor. First, ACC from <italic>Photorhabdus luminescens</italic> was coexpressed with <italic>Petroselinum crispum</italic> 4CL, <italic>Petunia hybrida</italic> CHS, and <italic>Medicago sativa</italic> CHI, which resulted in the production of pinocembrin and naringenin with titers of 196 and 67&#x000a0;mg/L, respectively. Second, the biotin ligase (BPL) from <italic>P. luminescens</italic> was coexpressed and improved the titer of pinocembrin to 367&#x000a0;mg/L. Third, overexpression of <italic>E. coli</italic> endogenous acetyl-CoA synthetase resulted in further improvement of titer of pinocembrin up to 429&#x000a0;mg/L when supplemented with acetate at low level (Leonard et al. <xref ref-type="bibr" rid="CR33">2007</xref>). Alternatively, malonyl-CoA can also be synthesized from malonyl-CoA synthase MatB from malonate. When <italic>Rhizobium trifolii</italic> MatB and dicarboxylate carrier protein (MatC) were coexpressed with 4CL, CHS, and CHI in <italic>E. coli</italic>, which was supplemented with malonate, the maximal titer of pinocembrin reached 710&#x000a0;mg/L (Leonard et al. <xref ref-type="bibr" rid="CR34">2008</xref>). It is worth noting that the high titer was achieved by also adding 0.2&#x000a0;mM of cerulenin, which suppresses the activities of FabB/F that competes for the malonyl-CoA pool for fatty acid biosynthesis.</p></sec><sec id="Sec6"><title>Biocatalytic synthesis of simvastatin in <italic>E. coli</italic></title><p>In addition to serving as a heterologous host for the various PKSs discussed above, <italic>E. coli</italic> has also been engineered to catalyze the semisynthesis of important, polyketide-derived drug molecules. One example is the biocatalytic synthesis of simvastatin, an important cholesterol-lowing drug, which is the active ingredient of the blockbuster drug Zocor. Simvastatin is a statin, which is a family of compounds that that can inhibit the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the rate-limiting step in the biosynthesis of cholesterol (Freeman <xref ref-type="bibr" rid="CR14">2006</xref>). The first statin approved by the FDA, lovastatin (Mevacor), is a fungal polyketide produced by <italic>Aspergillus terreus</italic> (Hendrickson et al. <xref ref-type="bibr" rid="CR16">1999</xref>; Kennedy et al. <xref ref-type="bibr" rid="CR26">1999</xref>). Simvastatin is a semi-synthesized derivative of lovastatin and is a more potent inhibitor of HMG-CoA reductase while exhibiting considerable less side effects in treating hypercholesterolemia (Manzoni and Rollini <xref ref-type="bibr" rid="CR37">2002</xref>). The only difference between lovastatin and simvastatin is the substitution of &#x003b1;-<italic>S</italic>-methylbutyrate with &#x003b1;-dimethylbutyrate side chain at C-8 position of the decaline core (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Currently, simvastatin is produced by a multistep chemical synthesis starting from lovastatin.
<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Synthesis of simvastatin using <italic>E. coli</italic> as the whole-cell biocatalyst</p></caption><graphic xlink:href="253_2010_2860_Fig4_HTML" id="MO4"/></fig>
</p><p>LovD is an acyltransferase found in the lovastatin biosynthetic pathway and is responsible for catalyzing the last step of lovastatin biosynthesis by acylating monacolin J with the &#x003b1;-<italic>S</italic>-methylbutyryl side chain synthesized by an iterative type I PKS LovF (Xie et al. <xref ref-type="bibr" rid="CR67">2009</xref>). Therefore, LovD was considered as a potential enzyme that can transfer a dimethylbutyryl side chain to monacolin J and afford simvastatin via the biocatalytic approach. To confirm the activities of LovD, Xie et al. (<xref ref-type="bibr" rid="CR65">2006</xref>) cloned and overexpressed LovD in <italic>E. coli</italic>. LovD was shown to regioselectively transfer &#x003b1;-<italic>S</italic>-methylbutyryl acyl group to monacolin J to produce lovastatin via a ping-pong mechanism. The authors demonstrated that LovD had broad substrate specificities toward the acyl carrier, the acyl substrate, and the decalin acyl acceptor. For example, it was able to accept membrane permeable SNAC thioesters, such as &#x003b1;-dimethyl-butyryl-SNAC (DMB-SNAC) as the acyl donor. Using <italic>E. coli</italic> as a whole-cell biocatalytic host, monacolin J was converted to simvastatin using a LovD expression strain and feeding of DMB-SNAC.</p><p>To improve the efficiency of the acyltransfer reaction and decrease the cost of the &#x003b1;-dimethylbutyryl acyl donor, further optimization of the substrate was performed (Xie and Tang <xref ref-type="bibr" rid="CR64">2007</xref>). Among the various thioesters assayed in this effort, the authors determined that &#x003b1;-dimethylbutyryl-<italic>S</italic>-methyl-3-mercaptopropionate (DMB-SMMP) is a superior substrate considering both the high initial turnover rate and the low raw material cost (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). When DMB-SMMP was supplemented to the <italic>E. coli</italic> host, nearly quantitative conversion (&#x0003e;99%) of monacolin J to simvastatin was achieved at 6&#x000a0;g/L. Subsequently, an engineered <italic>E. coli</italic> strain YT2, which contains a <italic>bioH</italic> knockout, was selected as the whole-cell host (Xie et al. <xref ref-type="bibr" rid="CR66">2007</xref>). BioH was previously reported as a carboxylesterase involved in the biotin biosynthetic pathway (Sanishvili et al. <xref ref-type="bibr" rid="CR53">2003</xref>). It was found that BioH rapidly hydrolyzed DMB-SMMP into dimethylbutyryl mercaptopropionic acid (DMB-SMPA; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>), which significantly lowered the overall turnover rate of the transformation. Using the YT2 strain as the host, the rate of simvastatin synthesis was doubled.</p><p>Directed evolution was then used to improve the LovD catalytic activity (Gao et al. <xref ref-type="bibr" rid="CR15">2009</xref>). The authors employed a combination of error prone polymerase chain reaction (<italic>ep-</italic>PCR), saturation mutagenesis, and site mutagenesis to generate LovD variants. <italic>E. coli</italic> libraries expressing mutant LovD were obtained, and the whole-cell activities of converting monacolin J to simvastatin were assayed by utilizing an agar-based diffusion screening assay. This method relied on the property that simvastatin inhibited the growth of the embedded <italic>Neurospora crassa</italic>. The best mutant G7 displayed ~11-fold higher increase in whole-cell activity compared to the wild-type LovD. Using this mutant, ~30&#x000a0;g/L monacolin J can be quantitatively converted to simvastatin within 1&#x000a0;day. The authors also attempted to provide a plausible explanation for the basis of enhanced catalytic efficiency of LovD by solving the crystal structures of parent LovD, an improved mutant G5, and G5 co-crystallized with lovastatin and simvastatin. Comparisons between these structures revealed that beneficial mutations promoted a more compact conformation that was favorable for catalysis. Using the combined strategies of protein engineering, metabolic engineering, and substrate optimization, the <italic>E. coli</italic> based platform is now more efficient, more cost-effective and environmentally friendlier than the synthetic approaches previously used in the semisynthesis of simvastatin.</p></sec><sec id="Sec7" sec-type="conclusion"><title>Conclusions</title><p>
<italic>E. coli</italic> is a highly versatile microorganism for reconstituting and engineering natural product biosynthetic pathways. Despite some limitations in protein expression, building block availability, and intracellular capacity for lipophilic compounds, combined efforts from different disciplines of biotechnology have rendered <italic>E. coli</italic> a suitable host for many PKSs. With the identification of an exploding number of biosynthetic pathways from recently sequenced organisms, engineered <italic>E. coli</italic> strains discussed in this review will play more important roles in the identification, dissection, and manipulation of new PKS machineries in the future.</p></sec></body><back><fn-group><fn><p>X. Gao and P. Wang contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Dr. Yit Heng Chooi for critical proof reading of the manuscript and insightful discussion. Research activities from our laboratory in this area are supported from funds from National Institute of Health, National Science Foundation, the Camille &#x00026; Henry Dreyfus Foundation, and the David and Lucile Packard Foundation.</p><sec id="d32e1056"><title>Open Access</title><p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>I</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name></person-group><article-title>Structure and function of the chalcone synthase superfamily of plant type III polyketide synthases</article-title><source>Nat Prod Rep</source><year>2010</year><volume>27</volume><issue>6</issue><fpage>809</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1039/b909988n</pub-id><pub-id pub-id-type="pmid">20358127</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>August</surname><given-names>PR</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Ning</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>TW</given-names></name><name><surname>Taylor</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>CG</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Hutchinson</surname><given-names>CR</given-names></name><name><surname>Floss</surname><given-names>HG</given-names></name></person-group><article-title>Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of amycolatopsis mediterranei s699</article-title><source>Chem Biol</source><year>1998</year><volume>5</volume><issue>2</issue><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(98)90141-7</pub-id><pub-id pub-id-type="pmid">9512878</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>MB</given-names></name><name><surname>Noel</surname><given-names>AJP</given-names></name></person-group><article-title>The chalcone synthase superfamily of type III polyketide synthases</article-title><source>Nat Prod Rep</source><year>2003</year><volume>20</volume><issue>1</issue><fpage>79</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1039/b100917f</pub-id><pub-id pub-id-type="pmid">12636085</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>MB</given-names></name><name><surname>Bowman</surname><given-names>ME</given-names></name><name><surname>Ferrer</surname><given-names>JL</given-names></name><name><surname>Schroder</surname><given-names>J</given-names></name><name><surname>Noel</surname><given-names>JP</given-names></name></person-group><article-title>An aldol switch discovered in stilbene synthases mediates cyclization specificity of type III polyketide synthases</article-title><source>Chem Biol</source><year>2004</year><volume>11</volume><issue>9</issue><fpage>1179</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2004.05.024</pub-id><pub-id pub-id-type="pmid">15380179</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>RH</given-names></name></person-group><article-title>Molecular engineering approaches to peptide, polyketide and other antibiotics</article-title><source>Nat Biotechnol</source><year>2006</year><volume>24</volume><issue>12</issue><fpage>1533</fpage><lpage>1540</lpage><pub-id pub-id-type="doi">10.1038/nbt1265</pub-id><pub-id pub-id-type="pmid">17160059</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boddy</surname><given-names>CN</given-names></name><name><surname>Hotta</surname><given-names>K</given-names></name><name><surname>Tse</surname><given-names>ML</given-names></name><name><surname>Watts</surname><given-names>RE</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Precursor-directed biosynthesis of epothilone in <italic>Escherichia coli</italic></article-title><source>J Am Chem Soc</source><year>2004</year><volume>126</volume><issue>24</issue><fpage>7436</fpage><lpage>7437</lpage><pub-id pub-id-type="doi">10.1021/ja048108s</pub-id><pub-id pub-id-type="pmid">15198579</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollag</surname><given-names>DM</given-names></name><name><surname>McQueney</surname><given-names>PA</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Hensens</surname><given-names>O</given-names></name><name><surname>Koupal</surname><given-names>L</given-names></name><name><surname>Liesch</surname><given-names>J</given-names></name><name><surname>Goetz</surname><given-names>M</given-names></name><name><surname>Lazarides</surname><given-names>E</given-names></name><name><surname>Woods</surname><given-names>CM</given-names></name></person-group><article-title>Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><issue>11</issue><fpage>2325</fpage><lpage>2333</lpage><pub-id pub-id-type="pmid">7757983</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>DE</given-names></name></person-group><article-title>Programming of erythromycin biosynthesis by a modular polyketide synthase</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>27517</fpage><lpage>27523</lpage><pub-id pub-id-type="doi">10.1074/jbc.R110.144618</pub-id><pub-id pub-id-type="pmid">20522551</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>DE</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Harnessing the biosynthetic code: combinations, permutations, and mutations</article-title><source>Science</source><year>1998</year><volume>282</volume><issue>5386</issue><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1126/science.282.5386.63</pub-id><pub-id pub-id-type="pmid">9756477</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortes</surname><given-names>J</given-names></name><name><surname>Haydock</surname><given-names>SF</given-names></name><name><surname>Roberts</surname><given-names>GA</given-names></name><name><surname>Bevitt</surname><given-names>DJ</given-names></name><name><surname>Leadlay</surname><given-names>PF</given-names></name></person-group><article-title>An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of <italic>Saccharopolyspora erythraea</italic></article-title><source>Nature</source><year>1990</year><volume>348</volume><issue>6297</issue><fpage>176</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/348176a0</pub-id><pub-id pub-id-type="pmid">2234082</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayem</surname><given-names>LC</given-names></name><name><surname>Carney</surname><given-names>JR</given-names></name><name><surname>Santi</surname><given-names>DV</given-names></name><name><surname>Pfeifer</surname><given-names>BA</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name><name><surname>Kealey</surname><given-names>JT</given-names></name></person-group><article-title>Metabolic engineering of a methylmalonyl-coa mutase-epimerase pathway for complex polyketide biosynthesis in <italic>Escherichia coli</italic></article-title><source>Biochemistry</source><year>2002</year><volume>41</volume><issue>16</issue><fpage>5193</fpage><lpage>5201</lpage><pub-id pub-id-type="doi">10.1021/bi015593k</pub-id><pub-id pub-id-type="pmid">11955068</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donadio</surname><given-names>S</given-names></name><name><surname>Katz</surname><given-names>L</given-names></name></person-group><article-title>Organization of the enzymatic domains in the multifunctional polyketide synthase involved in erythromycin formation in <italic>Saccharopolyspora erythraea</italic></article-title><source>Gene</source><year>1992</year><volume>111</volume><issue>1</issue><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(92)90602-L</pub-id><pub-id pub-id-type="pmid">1547954</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donadio</surname><given-names>S</given-names></name><name><surname>Staver</surname><given-names>MJ</given-names></name><name><surname>McAlpine</surname><given-names>JB</given-names></name><name><surname>Swanson</surname><given-names>SJ</given-names></name><name><surname>Katz</surname><given-names>L</given-names></name></person-group><article-title>Modular organization of genes required for complex polyketide biosynthesis</article-title><source>Science</source><year>1991</year><volume>252</volume><issue>5006</issue><fpage>675</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1126/science.2024119</pub-id><pub-id pub-id-type="pmid">2024119</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>MW</given-names></name></person-group><article-title>Statins, cholesterol, and the prevention of coronary heart disease</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><issue>2</issue><fpage>200</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1096/fj.06-0202ufm</pub-id><pub-id pub-id-type="pmid">16449790</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>XK</given-names></name><name><surname>Pashkov</surname><given-names>I</given-names></name><name><surname>Sawaya</surname><given-names>MR</given-names></name><name><surname>Laidman</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>WJ</given-names></name><name><surname>Cacho</surname><given-names>R</given-names></name><name><surname>Yeates</surname><given-names>TO</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Directed evolution and structural characterization of a simvastatin synthase</article-title><source>Chem Biol</source><year>2009</year><volume>16</volume><issue>10</issue><fpage>1064</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2009.09.017</pub-id><pub-id pub-id-type="pmid">19875080</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendrickson</surname><given-names>L</given-names></name><name><surname>Davis</surname><given-names>CR</given-names></name><name><surname>Roach</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>DK</given-names></name><name><surname>Aldrich</surname><given-names>T</given-names></name><name><surname>McAda</surname><given-names>PC</given-names></name><name><surname>Reeves</surname><given-names>CD</given-names></name></person-group><article-title>Lavastatin biosynthesis in <italic>Aspergillus terreus</italic>: characterization of blocked mutants, enzyme activities and a multifunctional polyketide synthase gene</article-title><source>Chem Biol</source><year>1999</year><volume>6</volume><issue>7</issue><fpage>429</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(99)80061-1</pub-id><pub-id pub-id-type="pmid">10381407</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertweck</surname><given-names>C</given-names></name><name><surname>Luzhetskyy</surname><given-names>A</given-names></name><name><surname>Rebets</surname><given-names>Y</given-names></name><name><surname>Bechthold</surname><given-names>A</given-names></name></person-group><article-title>Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork</article-title><source>Nat Prod Rep</source><year>2007</year><volume>24</volume><issue>1</issue><fpage>162</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1039/b507395m</pub-id><pub-id pub-id-type="pmid">17268612</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>CR</given-names></name></person-group><article-title>Biosynthetic studies of daunorubicin and tetracenomycin c</article-title><source>Chem Rev</source><year>1997</year><volume>97</volume><issue>7</issue><fpage>2525</fpage><lpage>2535</lpage><pub-id pub-id-type="doi">10.1021/cr960022x</pub-id><pub-id pub-id-type="pmid">11851469</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>EI</given-names></name><name><surname>Kaneko</surname><given-names>M</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Horinouchi</surname><given-names>S</given-names></name></person-group><article-title>Production of plant-specific flavanones by <italic>Escherichia coli</italic> containing an artificial gene cluster</article-title><source>Appl Environ Microbiol</source><year>2003</year><volume>69</volume><issue>5</issue><fpage>2699</fpage><lpage>2706</lpage><pub-id pub-id-type="doi">10.1128/AEM.69.5.2699-2706.2003</pub-id><pub-id pub-id-type="pmid">12732539</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julien</surname><given-names>B</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Ziermann</surname><given-names>R</given-names></name><name><surname>Goldman</surname><given-names>R</given-names></name><name><surname>Katz</surname><given-names>L</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Isolation and characterization of the epothilone biosynthetic gene cluster from <italic>Sorangium cellulosum</italic></article-title><source>Gene</source><year>2000</year><volume>249</volume><issue>1&#x02013;2</issue><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(00)00149-9</pub-id><pub-id pub-id-type="pmid">10831849</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>CM</given-names></name><name><surname>Katz</surname><given-names>L</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Engineered biosynthesis of a complete macrolactone in a heterologous host</article-title><source>Science</source><year>1994</year><volume>265</volume><issue>5171</issue><fpage>509</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1126/science.8036492</pub-id><pub-id pub-id-type="pmid">8036492</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Funa</surname><given-names>N</given-names></name><name><surname>Horinouchi</surname><given-names>S</given-names></name></person-group><article-title>Precursor-directed biosynthesis of stilbene methyl ethers in <italic>Escherichia coli</italic></article-title><source>Biotechnol J</source><year>2007</year><volume>2</volume><issue>10</issue><fpage>1286</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1002/biot.200700098</pub-id><pub-id pub-id-type="pmid">17806099</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Funa</surname><given-names>N</given-names></name><name><surname>Miyahisa</surname><given-names>I</given-names></name><name><surname>Horinouchi</surname><given-names>S</given-names></name></person-group><article-title>Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in <italic>Escherichia coli</italic></article-title><source>Chem Biol</source><year>2007</year><volume>14</volume><issue>6</issue><fpage>613</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2007.05.004</pub-id><pub-id pub-id-type="pmid">17584609</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Matsuzawa</surname><given-names>M</given-names></name><name><surname>Funa</surname><given-names>N</given-names></name><name><surname>Horinouch</surname><given-names>S</given-names></name></person-group><article-title>Production of curcuminoids by <italic>Escherichia coli</italic> carrying an artificial biosynthesis pathway</article-title><source>Microbiology</source><year>2008</year><volume>154</volume><fpage>2620</fpage><lpage>2628</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2008/018721-0</pub-id><pub-id pub-id-type="pmid">18757796</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Hirose</surname><given-names>Y</given-names></name><name><surname>Funa</surname><given-names>N</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Horinouchi</surname><given-names>S</given-names></name></person-group><article-title>Precursor-directed biosynthesis of curcumin analogs in <italic>Escherichia coli</italic></article-title><source>Biosci Biotechnol Biochem</source><year>2010</year><volume>74</volume><issue>3</issue><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1271/bbb.90866</pub-id><pub-id pub-id-type="pmid">20208337</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>Auclair</surname><given-names>K</given-names></name><name><surname>Kendrew</surname><given-names>SG</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Vederas</surname><given-names>JC</given-names></name><name><surname>Hutchinson</surname><given-names>CR</given-names></name></person-group><article-title>Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis</article-title><source>Science</source><year>1999</year><volume>284</volume><issue>5418</issue><fpage>1368</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1126/science.284.5418.1368</pub-id><pub-id pub-id-type="pmid">10334994</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>Murli</surname><given-names>S</given-names></name><name><surname>Kealey</surname><given-names>JT</given-names></name></person-group><article-title>6-deoxyerythronolide b analogue production in <italic>Escherichia coli</italic> through metabolic pathway engineering</article-title><source>Biochemistry</source><year>2003</year><volume>42</volume><issue>48</issue><fpage>14342</fpage><lpage>14348</lpage><pub-id pub-id-type="doi">10.1021/bi035157t</pub-id><pub-id pub-id-type="pmid">14640703</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosla</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>AY</given-names></name><name><surname>Schnarr</surname><given-names>NA</given-names></name><name><surname>Cane</surname><given-names>DE</given-names></name></person-group><article-title>Structure and mechanism of the 6-deoxyerythronolide b synthase</article-title><source>Annu Rev Biochem</source><year>2007</year><volume>76</volume><fpage>195</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.76.053105.093515</pub-id><pub-id pub-id-type="pmid">17328673</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>PJ</given-names></name><name><surname>Zawada</surname><given-names>RJX</given-names></name><name><surname>McDaniel</surname><given-names>R</given-names></name><name><surname>Hutchinson</surname><given-names>CR</given-names></name><name><surname>Hopwood</surname><given-names>DA</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Rational design and engineered biosynthesis of a novel 18-carbon aromatic polyketide</article-title><source>J Am Chem Soc</source><year>1997</year><volume>119</volume><issue>4</issue><fpage>635</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1021/ja962888q</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambalot</surname><given-names>RH</given-names></name><name><surname>Gehring</surname><given-names>AM</given-names></name><name><surname>Flugel</surname><given-names>RS</given-names></name><name><surname>Zuber</surname><given-names>P</given-names></name><name><surname>LaCelle</surname><given-names>M</given-names></name><name><surname>Marahiel</surname><given-names>MA</given-names></name><name><surname>Reid</surname><given-names>R</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name></person-group><article-title>A new enzyme superfamily&#x02014;the phosphopantetheinyl transferases</article-title><source>Chem Biol</source><year>1996</year><volume>3</volume><issue>11</issue><fpage>923</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(96)90181-7</pub-id><pub-id pub-id-type="pmid">8939709</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>J</given-names></name><name><surname>Tran</surname><given-names>C</given-names></name><name><surname>Licari</surname><given-names>P</given-names></name><name><surname>Galazzo</surname><given-names>J</given-names></name></person-group><article-title>Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide b in <italic>Escherichia coli</italic></article-title><source>J Biotechnol</source><year>2004</year><volume>110</volume><issue>1</issue><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2004.02.001</pub-id><pub-id pub-id-type="pmid">15099909</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>E</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Koffas</surname><given-names>MA</given-names></name></person-group><article-title>Functional expression of a p450 flavonoid hydroxylase for the biosynthesis of plant-specific hydroxylated flavonols in <italic>Escherichia coli</italic></article-title><source>Metab Eng</source><year>2006</year><volume>8</volume><issue>2</issue><fpage>172</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2005.11.001</pub-id><pub-id pub-id-type="pmid">16384722</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>E</given-names></name><name><surname>Lim</surname><given-names>KH</given-names></name><name><surname>Saw</surname><given-names>PN</given-names></name><name><surname>Koffas</surname><given-names>MAG</given-names></name></person-group><article-title>Engineering central metabolic pathways for high-level flavonoid production in <italic>Escherichia coli</italic></article-title><source>Appl Environ Microbiol</source><year>2007</year><volume>73</volume><issue>12</issue><fpage>3877</fpage><lpage>3886</lpage><pub-id pub-id-type="doi">10.1128/AEM.00200-07</pub-id><pub-id pub-id-type="pmid">17468269</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>E</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Fowler</surname><given-names>ZL</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Lim</surname><given-names>CG</given-names></name><name><surname>Lim</surname><given-names>KH</given-names></name><name><surname>Koffas</surname><given-names>MAG</given-names></name></person-group><article-title>Strain improvement of recombinant <italic>Escherichia coli</italic> for efficient production of plant flavonoids</article-title><source>Mol Pharm</source><year>2008</year><volume>5</volume><issue>2</issue><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1021/mp7001472</pub-id><pub-id pub-id-type="pmid">18333619</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linnemannstons</surname><given-names>P</given-names></name><name><surname>Schulte</surname><given-names>J</given-names></name><name><surname>del Mar</surname><given-names>PM</given-names></name><name><surname>Proctor</surname><given-names>RH</given-names></name><name><surname>Avalos</surname><given-names>J</given-names></name><name><surname>Tudzynski</surname><given-names>B</given-names></name></person-group><article-title>The polyketide synthase gene pks4 from <italic>Gibberella fujikuroi</italic> encodes a key enzyme in the biosynthesis of the red pigment bikaverin</article-title><source>Fungal Genet Biol</source><year>2002</year><volume>37</volume><issue>2</issue><fpage>134</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/S1087-1845(02)00501-7</pub-id><pub-id pub-id-type="pmid">12409099</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>SM</given-names></name><name><surname>Zhan</surname><given-names>J</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Enzymatic synthesis of aromatic polyketides using pks4 from <italic>Gibberella fujikuroi</italic></article-title><source>J Am Chem Soc</source><year>2007</year><volume>129</volume><issue>35</issue><fpage>10642</fpage><lpage>10643</lpage><pub-id pub-id-type="doi">10.1021/ja074865p</pub-id><pub-id pub-id-type="pmid">17696354</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzoni</surname><given-names>M</given-names></name><name><surname>Rollini</surname><given-names>N</given-names></name></person-group><article-title>Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs</article-title><source>Appl Environ Microbiol</source><year>2002</year><volume>58</volume><issue>5</issue><fpage>555</fpage><lpage>564</lpage></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsden</surname><given-names>AFA</given-names></name><name><surname>Wilkinson</surname><given-names>B</given-names></name><name><surname>Cortes</surname><given-names>J</given-names></name><name><surname>Dunster</surname><given-names>NJ</given-names></name><name><surname>Staunton</surname><given-names>J</given-names></name><name><surname>Leadlay</surname><given-names>PF</given-names></name></person-group><article-title>Engineering broader specificity into an antibiotic-producing polyketide synthase</article-title><source>Science</source><year>1998</year><volume>279</volume><issue>5348</issue><fpage>199</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1126/science.279.5348.199</pub-id><pub-id pub-id-type="pmid">9422686</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDaniel</surname><given-names>R</given-names></name><name><surname>Ebertkhosla</surname><given-names>S</given-names></name><name><surname>Hopwood</surname><given-names>DA</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Engineered biosynthesis of novel polyketides</article-title><source>Science</source><year>1993</year><volume>262</volume><issue>5139</issue><fpage>1546</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1126/science.8248802</pub-id><pub-id pub-id-type="pmid">8248802</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDaniel</surname><given-names>R</given-names></name><name><surname>Ebertkhosla</surname><given-names>S</given-names></name><name><surname>Hopwood</surname><given-names>DA</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Rational design of aromatic polyketide natural-products by recombinant assembly of enzymatic subunits</article-title><source>Nature</source><year>1995</year><volume>375</volume><issue>6532</issue><fpage>549</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/375549a0</pub-id><pub-id pub-id-type="pmid">7791871</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyahisa</surname><given-names>I</given-names></name><name><surname>Kaneko</surname><given-names>M</given-names></name><name><surname>Funa</surname><given-names>N</given-names></name><name><surname>Kawasaki</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>H</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Horinouchi</surname><given-names>S</given-names></name></person-group><article-title>Efficient production of (2s)-flavanones by <italic>Escherichia coli</italic> containing an artificial biosynthetic gene cluster</article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>68</volume><issue>4</issue><fpage>498</fpage><lpage>504</lpage></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyahisa</surname><given-names>I</given-names></name><name><surname>Funa</surname><given-names>N</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Martens</surname><given-names>S</given-names></name><name><surname>Moriguchi</surname><given-names>T</given-names></name><name><surname>Horinouchi</surname><given-names>S</given-names></name></person-group><article-title>Combinatorial biosynthesis of flavones and flavonols in <italic>Escherichia coli</italic></article-title><source>Appl Environ Microbiol</source><year>2006</year><volume>71</volume><issue>1</issue><fpage>53</fpage><lpage>58</lpage></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murli</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>Dayem</surname><given-names>LC</given-names></name><name><surname>Carney</surname><given-names>JR</given-names></name><name><surname>Kealey</surname><given-names>JT</given-names></name></person-group><article-title>Metabolic engineering of <italic>Escherichia coli</italic> for improved 6-deoxyerythronolide b production</article-title><source>J Ind Microbiol Biotechnol</source><year>2003</year><volume>30</volume><issue>8</issue><fpage>500</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1007/s10295-003-0073-x</pub-id><pub-id pub-id-type="pmid">12898389</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murli</surname><given-names>S</given-names></name><name><surname>MacMillan</surname><given-names>KS</given-names></name><name><surname>Hu</surname><given-names>ZH</given-names></name><name><surname>Ashley</surname><given-names>GW</given-names></name><name><surname>Dong</surname><given-names>SD</given-names></name><name><surname>Kealey</surname><given-names>JT</given-names></name><name><surname>Reeves</surname><given-names>CD</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name></person-group><article-title>Chemobiosynthesis of novel 6-deoxyerythronolide b analogues by mutation of the loading module of 6-deoxyerythronolide b synthase 1</article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>71</volume><issue>8</issue><fpage>4503</fpage><lpage>4509</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.8.4503-4509.2005</pub-id><pub-id pub-id-type="pmid">16085842</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutka</surname><given-names>SC</given-names></name><name><surname>Carney</surname><given-names>JR</given-names></name><name><surname>Liu</surname><given-names>YQ</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name></person-group><article-title>Heterologous production of epothilone c and d in <italic>Escherichia coli</italic></article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><issue>4</issue><fpage>1321</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1021/bi052075r</pub-id><pub-id pub-id-type="pmid">16430229</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olano</surname><given-names>C</given-names></name><name><surname>Mendez</surname><given-names>C</given-names></name><name><surname>Salas</surname><given-names>JA</given-names></name></person-group><article-title>Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis</article-title><source>Nat Prod Rep</source><year>2009</year><volume>26</volume><issue>5</issue><fpage>628</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1039/b822528a</pub-id><pub-id pub-id-type="pmid">19387499</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olano</surname><given-names>C</given-names></name><name><surname>Mendez</surname><given-names>C</given-names></name><name><surname>Salas</surname><given-names>JA</given-names></name></person-group><article-title>Post-pks tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis</article-title><source>Nat Prod Rep</source><year>2010</year><volume>27</volume><issue>4</issue><fpage>571</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1039/b911956f</pub-id><pub-id pub-id-type="pmid">20352666</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiru</surname><given-names>S</given-names></name><name><surname>Menzella</surname><given-names>HG</given-names></name><name><surname>Rodriguez</surname><given-names>E</given-names></name><name><surname>Carney</surname><given-names>J</given-names></name><name><surname>Gramajo</surname><given-names>H</given-names></name></person-group><article-title>Production of the potent antibacterial polyketide erythromycin c in <italic>Escherichia coli</italic></article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>71</volume><issue>5</issue><fpage>2539</fpage><lpage>2547</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.5.2539-2547.2005</pub-id><pub-id pub-id-type="pmid">15870344</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname><given-names>BA</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Biosynthesis of polyketides in heterologous hosts</article-title><source>Microbiol Mol Biol Rev</source><year>2001</year><volume>65</volume><issue>1</issue><fpage>106</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1128/MMBR.65.1.106-118.2001</pub-id><pub-id pub-id-type="pmid">11238987</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname><given-names>BA</given-names></name><name><surname>Admiraal</surname><given-names>SJ</given-names></name><name><surname>Gramajo</surname><given-names>H</given-names></name><name><surname>Cane</surname><given-names>DE</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Biosynthesis of complex polyketides in a metabolically engineered strain of <italic>E. coli</italic></article-title><source>Science</source><year>2001</year><volume>291</volume><issue>5509</issue><fpage>1790</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1126/science.1058092</pub-id><pub-id pub-id-type="pmid">11230695</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>ZH</given-names></name><name><surname>Licari</surname><given-names>P</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Process and metabolic strategies for improved production of escherichia coli-derived 6-deoxyetythronolide b</article-title><source>Appl Environ Microbiol</source><year>2002</year><volume>68</volume><issue>7</issue><fpage>3287</fpage><lpage>3292</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.7.3287-3292.2002</pub-id><pub-id pub-id-type="pmid">12089005</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadri</surname><given-names>LE</given-names></name><name><surname>Weinreb</surname><given-names>PH</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>MM</given-names></name><name><surname>Zuber</surname><given-names>P</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name></person-group><article-title>Characterization of sfp, a <italic>Bacillus subtilis</italic> phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases</article-title><source>Biochemistry</source><year>1998</year><volume>37</volume><issue>6</issue><fpage>1585</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1021/bi9719861</pub-id><pub-id pub-id-type="pmid">9484229</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanishvili</surname><given-names>R</given-names></name><name><surname>Yakunin</surname><given-names>AF</given-names></name><name><surname>Laskowski</surname><given-names>RA</given-names></name><name><surname>Skarina</surname><given-names>T</given-names></name><name><surname>Evdokimova</surname><given-names>E</given-names></name><name><surname>Doherty-Kirby</surname><given-names>A</given-names></name><name><surname>Lajoie</surname><given-names>GA</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name><name><surname>Arrowsmith</surname><given-names>CH</given-names></name><name><surname>Savchenko</surname><given-names>A</given-names></name><name><surname>Joachimiak</surname><given-names>A</given-names></name><name><surname>Edwards</surname><given-names>AM</given-names></name></person-group><article-title>Integrating structure, bioinformatics, and enzymology to discover function: BioH, a new carboxylesterase from <italic>Escherichia coli</italic></article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>28</issue><fpage>26039</fpage><lpage>26045</lpage><pub-id pub-id-type="doi">10.1074/jbc.M303867200</pub-id><pub-id pub-id-type="pmid">12732651</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schupp</surname><given-names>T</given-names></name><name><surname>Toupet</surname><given-names>C</given-names></name><name><surname>Engel</surname><given-names>N</given-names></name><name><surname>Goff</surname><given-names>S</given-names></name></person-group><article-title>Cloning and sequence analysis of the putative rifamycin polyketide synthase gene cluster from <italic>Amycolatopsis mediterranei</italic></article-title><source>FEMS Microbiol Lett</source><year>1998</year><volume>159</volume><issue>2</issue><fpage>201</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.1998.tb12861.x</pub-id><pub-id pub-id-type="pmid">9503613</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staunton</surname><given-names>J</given-names></name><name><surname>Weissman</surname><given-names>KJ</given-names></name></person-group><article-title>Polyketide biosynthesis: a millennium review</article-title><source>Nat Prod Rep</source><year>2001</year><volume>18</volume><issue>4</issue><fpage>380</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1039/a909079g</pub-id><pub-id pub-id-type="pmid">11548049</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>L</given-names></name><name><surname>Carney</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>L</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name><name><surname>Julien</surname><given-names>B</given-names></name></person-group><article-title>Cloning and heterologous expression of the epothilone gene cluster</article-title><source>Science</source><year>2000</year><volume>287</volume><issue>5453</issue><fpage>640</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1126/science.287.5453.640</pub-id><pub-id pub-id-type="pmid">10649995</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Tsai</surname><given-names>SC</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Polyketide chain length control by chain length factor</article-title><source>J Am Chem Soc</source><year>2003</year><volume>125</volume><issue>42</issue><fpage>12708</fpage><lpage>12709</lpage><pub-id pub-id-type="doi">10.1021/ja0378759</pub-id><pub-id pub-id-type="pmid">14558809</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>R</given-names></name></person-group><article-title>A biosynthetic classification of fungal and streptomycete fused-ring aromatic polyketides</article-title><source>ChemBioChem</source><year>2001</year><volume>2</volume><issue>9</issue><fpage>612</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1002/1439-7633(20010903)2:9&#x0003c;612::AID-CBIC612&#x0003e;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">11828498</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Pfeifer</surname><given-names>BA</given-names></name></person-group><article-title>6-Deoxyerythronolide b production through chromosomal localization of the deoxyerythronolide b synthase genes in <italic>E. coli</italic></article-title><source>Metab Eng</source><year>2008</year><volume>10</volume><issue>1</issue><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2007.09.002</pub-id><pub-id pub-id-type="pmid">17959404</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Boghigian</surname><given-names>BA</given-names></name><name><surname>Pfeifer</surname><given-names>BA</given-names></name></person-group><article-title>Improving heterologous polyketide production in <italic>Escherichia coli</italic> by overexpression of an s-adenosylmethionine synthetase gene</article-title><source>Appl Environ Microbiol</source><year>2007</year><volume>77</volume><issue>2</issue><fpage>367</fpage><lpage>373</lpage></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Rude</surname><given-names>MA</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title>Engineered biosynthesis of an ansamycin polyketide precursor in <italic>Escherichia coli</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><issue>17</issue><fpage>9774</fpage><lpage>9778</lpage><pub-id pub-id-type="doi">10.1073/pnas.1632167100</pub-id><pub-id pub-id-type="pmid">12888623</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisshaar</surname><given-names>B</given-names></name><name><surname>Jenkins</surname><given-names>GI</given-names></name></person-group><article-title>Phenylpropanoid biosynthesis and its regulation</article-title><source>Curr Opin Plant Biol</source><year>1998</year><volume>1</volume><issue>3</issue><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1016/S1369-5266(98)80113-1</pub-id><pub-id pub-id-type="pmid">10066590</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissman</surname><given-names>KJ</given-names></name><name><surname>Leadlay</surname><given-names>PF</given-names></name></person-group><article-title>Combinatorial biosynthesis of reduced polyketides</article-title><source>Nat Rev Microbiol</source><year>2005</year><volume>3</volume><issue>12</issue><fpage>925</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1287</pub-id><pub-id pub-id-type="pmid">16322741</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>XK</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Efficient synthesis of simvastatin by use of whole-cell biocatalysis</article-title><source>Appl Environ Microbiol</source><year>2007</year><volume>73</volume><issue>7</issue><fpage>2054</fpage><lpage>2060</lpage><pub-id pub-id-type="doi">10.1128/AEM.02820-06</pub-id><pub-id pub-id-type="pmid">17277201</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>XK</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Wojcicki</surname><given-names>WA</given-names></name><name><surname>Wang</surname><given-names>CCC</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Biosynthesis of lovastatin analogs with a broadly specific acyltransferase</article-title><source>Chem Biol</source><year>2006</year><volume>13</volume><fpage>1161</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2006.09.008</pub-id><pub-id pub-id-type="pmid">17113998</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>XK</given-names></name><name><surname>Wong</surname><given-names>WW</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Improving simvastatin bioconversion in <italic>Escherichia coli</italic> by deletion of BioH</article-title><source>Metab Eng</source><year>2007</year><volume>9</volume><issue>4</issue><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2007.05.006</pub-id><pub-id pub-id-type="pmid">17625941</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>XK</given-names></name><name><surname>Meehan</surname><given-names>MJ</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Dorrestein</surname><given-names>PC</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Acyltransferase mediated polyketide release from a fungal megasynthase</article-title><source>J Am Chem Soc</source><year>2009</year><volume>131</volume><issue>24</issue><fpage>8388</fpage><lpage>8389</lpage><pub-id pub-id-type="doi">10.1021/ja903203g</pub-id><pub-id pub-id-type="pmid">19530726</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Q</given-names></name><name><surname>Ashley</surname><given-names>G</given-names></name><name><surname>Hutchinson</surname><given-names>CR</given-names></name><name><surname>Santi</surname><given-names>DV</given-names></name></person-group><article-title>A multiplasmid approach to preparing large libraries of polyketides</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><issue>21</issue><fpage>11740</fpage><lpage>11745</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.21.11740</pub-id><pub-id pub-id-type="pmid">10518520</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Koffas</surname><given-names>MAG</given-names></name></person-group><article-title>Biosynthesis of 5-deoxyflavanones in microorganisms</article-title><source>Biotechnol J</source><year>2007</year><volume>2</volume><issue>10</issue><fpage>1250</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1002/biot.200700119</pub-id><pub-id pub-id-type="pmid">17806100</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Engineered biosynthesis of bacterial aromatic polyketides in <italic>Escherichia coli</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><issue>52</issue><fpage>20683</fpage><lpage>20688</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809084105</pub-id><pub-id pub-id-type="pmid">19075227</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Boghigian</surname><given-names>BA</given-names></name><name><surname>Pfeifer</surname><given-names>BA</given-names></name></person-group><article-title>Investigating the role of native propionyl-coa and methylmalonyl-coa metabolism on heterologous polyketide production in <italic>Escherichia coli</italic></article-title><source>Biotechnol Bioeng</source><year>2010</year><volume>105</volume><issue>3</issue><fpage>567</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1002/bit.22560</pub-id><pub-id pub-id-type="pmid">19806677</pub-id></element-citation></ref></ref-list></back></article>